Serum Apolipoprotein A-Iv Level in HCV Related Liver Diseases
Journal Title: Journal of Medical Science And clinical Research - Year 2015, Vol 3, Issue 12
Abstract
Background: Hepatitis C virus (HCV) is a globally prevalent pathogen and chronic infection eventually causes cirrhosis leading to hepatocellular carcinoma (HCC) and ultimately death. Accurate assessment of liver fibrosis has become increasingly important as it allows for individualized management. Liver plays a key role in the metabolism of plasma apolipoproteins. Apolipoprotein A-IV (apoA-IV) is a component of intestinally derived, triglyceride-rich lipoproteins. Objective: The present work was designed to study the level of apo A-IV in HCV related liver diseases. Methods: Sixty treatment-naive patients with HCV related liver disease were enrolled in the study. They were classified as follow: twenty patients with chronic HCV infection (stage of fibrosis ≤ F3), twenty patients with HCV related liver cirrhosis, twenty patients with HCV related HCC and ten normal subjects as control. Serum level of apoA-IV was measured using enzyme linked immunosorbant assay (ELISA). Liver biopsies from patients with chronic HCV were examined to assess histological activity grade and fibrosis stage according to METAVIR scoring system and triphasic CT for HCC patients was performed. Results: Apo A-IV level was significantly lower in liver cirrhosis than chronic hepatitis patients with a cutoff point of ˂36.4 (p<0.001). The receiver operating characteristic (ROC) curve showed an area under the curve (AUC) of 0.990 (P < 0.001), a sensitivity of 100% and a specificity of 90% for diagnosis of cirrhosis. Also, it was significantly lower in liver cirrhosis than HCC patients with a cutoff point ≤25.1 (p<0.001). The ROC showed AUC of 0.876, a sensitivity of 80.0 % and a specificity of 93.33% for diagnosis of HCC. Conclusion: Serum apo A-IV showed bi-modal elevation in HCV related liver diseases and could be used as a noninvasive marker for liver cirrhosis in patients with chronic HCV infection and could be a promising marker for early detection of HCC in HCV hepatic cirrhosis.
Authors and Affiliations
Ibrahim E. H.
Keywords
Related Articles
- EP ID EP213094
- DOI -
- Views 71
- Downloads 0
Probiotics: Eat What You Like And Let The Food Fight It Out Inside
Probiotics are live nonpathogenic microorganisms which provide health benefits by adding "good" microbes to fight against "bad" microbes. When effective, the good microbes reduce the bacterial threat of the bad microbes...
Invasive Aspergillosis Following Liver Transplantation and Its Successful Management
Oppurtunistic infections represent a major cause of mortality and morbidity following liver transplantation. Mortality rate is high for invasive fungal infections following liver transplantation, candidiasis is the most...
Accelerated Fractionation Radiotherapy in Head and Neck Cancer: A Boon to Centers with High Patient-Resource Ratio
Background: Head and Neck Squamous Cell Carcinoma (HNSCC) is a major cause of morbidity and mortality in India. Though concurrent Chemo-Radiation treatment is the standard of care, optimal radiation schedule in patients...
An Etiological Study of Upper Gastro-intestinal Bleeding with Special Reference to Helicobacter Pylori Infection in Peptic Ulcer Disease
OBJECTVE: Upper gastro intestinal bleeding is a common life threatening emergency resulting in a large number of hospital admission. Peptic ulcers are the most common cause of UGIB. Helicobacter pylori plays a pivotal ro...
Comparison of Transvaginal Sonography and Hysteroscopy in diagnosis of intrauterine pathologies in infertile women
Infertility is a problem as old as mankind itself. Approximately 10% to 15% of all married couple are infertile with female factors accounting for approximately 40% of these cases which include uterine tubal, ovarian and...